echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: After a stroke, people diagnosed with atrial fibrillation are at higher risk of death

    Neurology: After a stroke, people diagnosed with atrial fibrillation are at higher risk of death

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The close connection between atrial fibrillation (AF), stroke, and oral anticoagulation therapy to prevent thromboembolism has been widely accepted.


    Stroke prevention thrombosis

    Specifically, 25% of patients with ischemic stroke will experience atrial fibrillation.


    Diagnostic FDA medsci.


    They used to create an initial cohort of accidental stroke patients.


    They found 1,489 individuals with ischemic stroke events, 985 individuals did not develop atrial fibrillation at any time during the study period, 215 individuals had KAF before stroke, and 160 individuals had atrial fibrillation ≤6 months after stroke, 129 People have atrial fibrillation more than 6 months after the stroke.


    After a median follow-up of 4.


    FDAS>6 months group was 12.


    FDAS>6 months group was 12.


    The significance of this study is that it found that the AFDAS group had the highest risk of death, a phenomenon that cannot be explained by clinical comorbidities or the use of antithrombotic therapy.


    The significance of this study is that it found that the AFDAS group had the highest risk of death, a phenomenon that cannot be explained by clinical comorbidities or the use of antithrombotic therapy.




    neurology.
    org/content/96/12/e1655" target="_blank" rel="noopener">The Stroke, the Timing Diagnosis of Atrial Fibrillation, and Risk of Death
    neurology.
    org/content/96/12/e1655" target="_blank" rel="noopener">Anjali Bhatla, Yuliya Borovskiy, Ronit Katz, et Al.

    neurology.
    org/content/96/12/e1655" target="_blank" rel="noopener">.
    Neurology-Mar 2021, 96 (12 is)-e1655 e1662; the DOI: 10.
    1212 / WNL.
    0000000000011633

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.